Featured Research

from universities, journals, and other organizations

New Approach To Thwarting Inflammation

Date:
September 5, 2000
Source:
Howard Hughes Medical Institute
Summary:
Howard Hughes Medical Institute (HHMI) researchers have discovered a way to shut down the inflammatory response in cells that spares related mechanisms that cells need in order to function properly. Their experiments have demonstrated that such treatment relieves inflammation in mice with surprising effectiveness.

September 1, 2000 — Howard Hughes Medical Institute (HHMI) researchers have discovered a way to shut down the inflammatory response in cells that spares related mechanisms that cells need in order to function properly. Their experiments have demonstrated that such treatment relieves inflammation in mice with surprising effectiveness.

Related Articles


In an article published in the September 1, 2000, issue of Science, HHMI investigator Sankar Ghosh and his colleagues at Yale University report that they have found a way to short circuit NF-kB, a central coordinator of the cell’s inflammatory response. When NF-kB is triggered by an external chemical signal, NF-kB sets in motion the gene expression machinery that drives inflammation.

"It has become clear over the years that NF-kB plays a crucial, evolutionarily conserved role in the cell’s response for getting rid of pathogens," said Ghosh. "As a byproduct of this immune response, inflammation can get out of control and cause pathogenic states. We now know that many diseases that at first glance don’t seem to have much in common actually have inflammation as an underlying reason for their pathology." Alzheimer’s disease, for example, might well involve inflammatory responses that damage brain tissue, Ghosh noted.

The most widely used anti-inflammatory drugs, including salicylates such as aspirin, and steroids, inhibit NF-kB to some extent, but they can also have severe side effects. The great need for more precise inhibitors of inflammation prompted Ghosh and his colleagues to look at ways to block inflammation by interfering with NF-kB.

The scientists knew that in unstimulated cells NF-kB remains in the cell’s cytoplasm attached to inhibitory proteins known as IkBs. When an external inflammatory signal affects the cell, the IkB-kinase (IKK) complex—which consists of a pair of catalytic enzymes—is activated and phosphorylates the IkB proteins. The phosphorylated IkB is then rapidly degraded, thus freeing NF-kB to trigger the inflammatory process.

While the majority of research on blocking the inflammatory process has focused on blocking the catalytic activity of the IKK complex itself, Ghosh and his colleagues chose another route. "By themselves, the enzymes of the IKK complex don’t respond to signals," explained Ghosh. "Each enzyme needs a regulatory subunit protein called NEMO, and it has been shown that when NEMO is knocked out in mice, NF-kB becomes unresponsive to signaling."

In a series of biochemical experiments, Ghosh and his colleagues sought to identify the minimal region of the IKK enzymes that interacted with NEMO. "We were quite surprised to find that a very small region of the IKK enzymes seemed to be completely responsible for interacting with NEMO," said Ghosh. The scientists called the region the NEMO-binding domain (NBD).

"We reasoned that if the NBD was such a small region, then maybe we could use it as a way to disrupt the whole IKK complex and prevent it from forming," said Ghosh. Sure enough, when the scientists synthesized a small peptide that mimicked the NBD and put it into cells, they discovered that NF-kB activation was blocked significantly.

"Then we raised the stakes," said Ghosh. "We decided to see if this blocking method would work in vivo in animals." The scientists used the NBD peptide to attempt to block inflammation in two mouse models where chemicals are used to induce inflammation artificially.

"In both models, when we injected our peptide, we observed quite a dramatic amelioration of the inflammatory process," said Ghosh. "I think that the remarkable anti-inflammatory effect that we achieved validates the approach of relieving inflammation by interfering with the activation of NF-kB alone. This approach should become a major focus of future research."

Ghosh also said that blocking the activation of NF-kB by external inflammatory factors quite likely spares the basal activity of the NF-kB machinery that operates via a different pathway, and which cells need for normal function.

"One of the concerns that has been raised about inhibiting NF-kB, is that NF-kB also has some beneficial effects, such as helping cells survive apoptosis, or programmed cell death," said Ghosh.

Ghosh and his colleagues are planning further studies to investigate the NEMO-IKK interaction. They are going to test the NBD peptide on mouse models of asthma and other diseases that involve inflammation. They also hope to initiate collaborations with pharmaceutical companies to develop mimics of the NBD peptide that can be used as precise inhibitors of inflammation.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "New Approach To Thwarting Inflammation." ScienceDaily. ScienceDaily, 5 September 2000. <www.sciencedaily.com/releases/2000/09/000904093033.htm>.
Howard Hughes Medical Institute. (2000, September 5). New Approach To Thwarting Inflammation. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2000/09/000904093033.htm
Howard Hughes Medical Institute. "New Approach To Thwarting Inflammation." ScienceDaily. www.sciencedaily.com/releases/2000/09/000904093033.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins